intermediate age-related macular degeneration Archives - Insight Presented by Prime Creative Media Thu, 05 May 2022 05:21:27 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png intermediate age-related macular degeneration Archives - Insight 32 32 Prof Robyn Guymer to head up new 2RT study for iAMD https://www.insightnews.com.au/prof-robyn-guymer-to-head-up-new-2rt-study-for-iamd/ Thu, 05 May 2022 05:21:27 +0000 https://www.insightnews.com.au/?p=27164
Nova Eye Medical is commercialising 2RT through its subsidiary AlphaRET.

Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and Drug Administration (FDA) to pave a clear approval pathway for its pioneeringRead More

The post Prof Robyn Guymer to head up new 2RT study for iAMD appeared first on Insight.

]]>
Nova Eye Medical is commercialising 2RT through its subsidiary AlphaRET.
Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and Drug Administration (FDA) to pave a clear approval pathway for its pioneering
Read More

The post Prof Robyn Guymer to head up new 2RT study for iAMD appeared first on Insight.

]]> Five-year post-LEAD trial garners positive results for 2RT https://www.insightnews.com.au/five-year-post-lead-trial-garners-positive-results-for-2rt/ Tue, 09 Mar 2021 20:15:01 +0000 http://www.insightnews.com.au/?p=19373
Nova Eye Medical is commercialising 2RT through its subsidiary AlphaRET.

The post Five-year post-LEAD trial garners positive results for 2RT appeared first on Insight.

]]>
Nova Eye Medical is commercialising 2RT through its subsidiary AlphaRET.
Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its 2RT nano-pulse ophthalmic laser therapy. Conducted from 2012 to 2018, the
Read More

The post Five-year post-LEAD trial garners positive results for 2RT appeared first on Insight.

]]> Aussie firm reveals next-gen MIGS device in pipeline https://www.insightnews.com.au/aussie-firm-reveals-next-gen-migs-device-in-pipeline/ Mon, 31 Aug 2020 21:40:12 +0000 http://www.insightnews.com.au/?p=16458
The company's sales growth has been driven by its iTrack MIGS device.

The post Aussie firm reveals next-gen MIGS device in pipeline appeared first on Insight.

]]>
The company's sales growth has been driven by its iTrack MIGS device.
Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for
Read More

The post Aussie firm reveals next-gen MIGS device in pipeline appeared first on Insight.

]]>